Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported - Concepedia

Concepedia

Publication | Open Access

Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported

DOI Full Paper Access

85

Citations

17

References

2020

Year

Marianno Franzini, Luigi Valdenassi, Giovanni Ricevuti, Salvatore Chirumbolo, Markus Depfenhart, Dario Bertossi, Umberto Tirelli

International Immunopharmacology

Covid-19 PandemicImmunologyAntiviral TherapyInfectious Respiratory DiseasePreliminary EvidenceImmunotherapyMedicineImmunoceutical TherapyCovid-19

References

	Year	Citations

Page 1